All Stories

2 years after leaving PhRMA, AstraZeneca opts back in

Two years after leaving the Pharmaceutical Research and Manufacturers of America, AstraZeneca has rejoined the industry trade group.

Apr 22, 2025 - 21:42
 0
2 years after leaving PhRMA, AstraZeneca opts back in
Two years after leaving the Pharmaceutical Research and Manufacturers of America, AstraZeneca has rejoined the industry trade group.
Read More

Tags:

Previous Article

FTC Sues Uber for Making Uber One Subscriptions ‘Unreasonably Difficult’ To Cancel

Next Article

U.S. Navy EA-18G Growler Carries Rare Four AGM-88E AARGM Loadout Against Houthis

Related Posts

Amid takeover talk, SpringWorks scores FDA nod for rare genetic disease treatment Gomekli

Amid takeover talk, SpringWorks scores FDA nod for rare...

Feb 12, 2025  0

Launch metrics of Madrigal's MASH drug Rezdiffra track 'exceptionally well,' CEO says

Launch metrics of Madrigal's MASH drug Rezdiffra track ...

Feb 27, 2025  0

Pfizer's blockbuster ADC Adcetris nabs FDA approval to treat large B-cell lymphoma

Pfizer's blockbuster ADC Adcetris nabs FDA approval to ...

Feb 12, 2025  0